Delivery Order SPE2DB25D3108-SPE2DB26FPBNM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for supply of Journavx 50 mg tablets (30-count packaging) valued at $3,048.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,536.24 to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets (30-count units) under a firm fixed price contract. The award was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,136.12 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Journavx 50 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Journavx 50 mg tablets (30-count units) valued at $1,808.88 under a firm fixed-price arrangement. This non-set-aside, competitively awarded delivery order is scheduled for completion by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $12,518.12 to AmerisourceBergen Drug Corp for Journavx 50 mg tablets (30-count packaging) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Journavx 50 mg tablets (30-count units) valued at $1,561.55. This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This delivery order, valued at $5,998.20, was awarded to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Journavx 50 mg tablets (30-count units) to support federal medical procurement needs. The contract represents a non-competitive, firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December...
- The Defense Logistics Agency awarded a $2,111.64 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Journavx 50 mg tablets (100-count unit dose packaging). This firm fixed-price contract, which is not set-aside and is competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,269.06 to AmerisourceBergen Drug Corp for JOURNAVX 50 MG tablets (30-count supply), with an ultimate completion date of September 17, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Journavx 50 mg tablets in unit dose packaging (100 count). This is a firm fixed-price delivery order with a ceiling value of $3,305.43, with an ultimate completion date of July 1, 2025. The award utilizes no set-aside designation and represents a competitively awarded contract. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB26FPBNMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,094.95 to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets (30-count units) under firm fixed pricing terms. The contract was competitively awarded without set-aside designation and is scheduled for completion by November 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent capability in delivering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 11/4/25 |